VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 206 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $717,747 | -72.4% | 29,260 | -73.9% | 0.00% | -75.0% |
| Q1 2023 | $2,603,889 | -69.5% | 111,899 | -66.8% | 0.01% | -78.9% |
| Q4 2022 | $8,528,153 | -99.9% | 336,948 | +7.1% | 0.06% | +18.8% |
| Q3 2022 | $6,066,085,000 | +4.5% | 314,631 | +38.1% | 0.05% | -9.4% |
| Q2 2022 | $5,802,931,000 | +9.0% | 227,834 | +10.1% | 0.05% | +23.3% |
| Q1 2022 | $5,321,853,000 | +15.7% | 206,915 | +88.4% | 0.04% | +30.3% |
| Q4 2021 | $4,598,958,000 | +24.4% | 109,839 | +29.3% | 0.03% | +22.2% |
| Q3 2021 | $3,698,242,000 | +24.9% | 84,978 | +35.7% | 0.03% | +17.4% |
| Q2 2021 | $2,959,822,000 | – | 62,602 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $14,609,161 | 17.42% |
| SB INVESTMENT ADVISERS (UK) LTD | 16,684,041 | $156,329,464 | 1.29% |
| Octagon Capital Advisors LP | 325,050 | $3,045,719 | 0.47% |
| SECTOR GAMMA AS | 148,538 | $1,391,801 | 0.36% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1,345,635 | $12,608,600 | 0.31% |
| ALGERT GLOBAL LLC | 449,685 | $4,214 | 0.20% |
| Quantamental Technologies LLC | 18,519 | $173,523 | 0.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 47,000 | $439,920 | 0.15% |
| DUALITY ADVISERS, LP | 123,871 | $1,160,671 | 0.14% |
| Empowered Funds, LLC | 385,135 | $3,608,715 | 0.11% |